跳至主要内容
临床试验/NCT03102203
NCT03102203Unknown不适用

Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Prospective Multicenter Clinical Trial With Multimodality MR Imaging

Jinling Hospital, China1 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2016年6月8日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
350
试验地点
1
主要终点
Ktrans

研究概览

简要总结

To evaluate the efficacy of multi-modality magnetic resonance quantitative parameters in evaluating the treatment effects of high-grade gliomas, and to provide new biomarkers for the establishment of new diagnostic criteria for the identification of true and pseudoprogression of high-grade gliomas.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with high-grade gliomas confirmed by pathology and have not been treated with concurrent chemoradiotherapy;
  • Written informed consent is obtained.

排除标准

  • Patients not suitable for enhanced MRI scanning of patients;
  • Patients who have not finished follow-up concurrent chemoradiotherapy or MR scanning.

结局指标

主要结局

Ktrans

时间窗: 10 months

The volume transfer constant in dynamic contrast-enhanced MR Imaging

次要结局

未报告次要终点

研究者

发起方
Jinling Hospital, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lu Guang Ming

Professor

Jinling Hospital, China

研究点 (1)

Loading locations...

相似试验